BSE filing, NSE: ENNATURE. Summary written from the filing by ALFA Finder's alert engine.
Ennature Bio Pharma Ltd: key numbers
- Share price
- ₹167.65
- Market cap
- ₹374.6 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.00 Cr
- Promoter holding
- 59.63%
- FII holding
- 2.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ennature Bio Pharma Ltd
All →Ennature Bio Pharma Management Change
Ennature Bio Pharma's board designated five individuals as Senior Management Personnel effective 12 November 2026. The appointments broaden the company's senior leadership structure.
Ennature Bio Pharma Other Announcement
Ennature Bio Pharma designated five senior managers (Heads/DGMs) as SMP per SEBI circular. This is a routine compliance intimation with no material business impact.
Ennature Bio Pharma Board Meeting Outcome
Ennature Bio Pharma's board approved adoption of new Articles of Association to align with SCRA Rules 1957 and group governance. The change is subject to shareholder approval.
Ennature Bio Pharma Q2 FY27 Results: Turns Profitable, Net Profit ₹4.9 Cr
Ennature Bio Pharma Ltd reported revenue from operations of ₹78.5 Cr (+45.1% YoY) and net profit of ₹4.9 Cr for Q2 FY27.
- Key figure
- Net profit ₹4.9 Cr
Ennature Bio Pharma Board Meeting Date
Ennature Bio Pharma will hold a board meeting on 12 November 2026 to consider unaudited second-quarter results ended September 2026. Trading window stays closed until 14 November.
Ennature Bio Pharma Capital Structure Change
Ennature Bio Pharma listed its equity shares on NSE and BSE on 4 November 2026. The company brings its API, biopolymer and nutraceutical businesses to public markets.
Other credit rating announcements
All →High Energy Batteries (India) Credit Rating
India Ratings reaffirmed High Energy Batteries' bank loan facilities at IND BBB/Stable/IND A3+. The rating covers INR 75 crore of facilities and the outlook remains stable.
Canara Bank Credit Rating
Moody's affirmed Canara Bank's Baa3 ratings and upgraded its baseline credit assessment to baa3 from ba1, with a stable outlook. Asset quality and capital improved.
Arman Financial Services Credit Rating
Arman Financial Services disclosed that CARE Ratings reaffirmed its 'CARE A-; Stable' rating on NCD facilities aggregating Rs 90.89 crore. The letter is dated November 19, 2026.
IGL Spirits Credit Rating
CARE Ratings assigned IGL Spirits a CARE A+ rating on its bank facilities. Rated facilities total Rs.1,050.11 crore across term, fund-based and non-fund-based limits.
Genus Power Infrastructures Credit Rating
CRISIL reaffirmed Genus Power's bank facilities rating at AA-/Positive and A1+ on commercial paper. The long-term outlook was revised from Stable to Positive.
Pace Digitek Credit Rating
CRISIL revised Pace Digitek's long-term outlook to Positive and assigned A-/Positive to proposed Rs.400 Crore NCDs. Bank facilities of Rs.1400 Crore were reaffirmed at A-/Positive and A2+.